These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10691600)

  • 1. Use of statins and fibrates in hyperlipidemic patients with neuromuscular disorders.
    Leung NM; Ooi TC; McQueen MJ
    Ann Intern Med; 2000 Mar; 132(5):418-9. PubMed ID: 10691600
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antilipemic agents, hypothyroidism, and rhabdomyolysis].
    Pía Iglesias G; Garrido Sanjuán JA; González González C; Sesma Sánchez P
    Rev Clin Esp; 2000 Apr; 200(4):236-7. PubMed ID: 10857417
    [No Abstract]   [Full Text] [Related]  

  • 3. Simvastatin, fenofibrate, and rhabdomyolysis.
    Jacob SS; Jacob S; Williams C; Deeg MA
    Diabetes Care; 2005 May; 28(5):1258. PubMed ID: 15855605
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of adverse events with fibrates.
    Alsheikh-Ali AA; Kuvin JT; Karas RH
    Am J Cardiol; 2004 Oct; 94(7):935-8. PubMed ID: 15464682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myositis and rhabdomyolysis associated with concurrent use of simvastatin and nefazodone.
    Jacobson RH; Wang P; Glueck CJ
    JAMA; 1997 Jan 22-29; 277(4):296-7. PubMed ID: 9002485
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fibrate and statine myopathy].
    Finsterer J
    Nervenarzt; 2003 Feb; 74(2):115-22. PubMed ID: 12596012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhabdomyolysis and acute renal failure associated with gemfibrozil therapy.
    Górriz JL; Sancho A; Lopez-Martin JM; Alcoy E; Catalán C; Pallardó LM
    Nephron; 1996; 74(2):437-8. PubMed ID: 8893176
    [No Abstract]   [Full Text] [Related]  

  • 8. Fenofibrate monotherapy induced rhabdomyolysis.
    Barker BJ; Goodenough RR; Falko JM
    Diabetes Care; 2003 Aug; 26(8):2482-3. PubMed ID: 12882895
    [No Abstract]   [Full Text] [Related]  

  • 9. Fenofibrate monotherapy-induced rhabdomyolysis in a patient with type-2 diabetes.
    Cetinkaya R; Uyanik A; Yildirim R; Bilen Y; Keles M
    Indian J Med Sci; 2008 Nov; 62(11):458-9. PubMed ID: 19265237
    [No Abstract]   [Full Text] [Related]  

  • 10. Statin induced myotoxicity.
    Sathasivam S
    Eur J Intern Med; 2012 Jun; 23(4):317-24. PubMed ID: 22560377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatitis and rhabdomyolysis associated with lovastatin-gemfibrozil therapy.
    Abdul-Ghaffar NU; el-Sonbaty MR
    J Clin Gastroenterol; 1995 Dec; 21(4):340-1. PubMed ID: 8583121
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone scintigraphy of drug-induced rhabdomyolysis: antihyperlipidemia agent.
    Takayama T; Tsuji S; Taki J; Michigishi T; Tonami N
    Clin Nucl Med; 1996 Dec; 21(12):988-9. PubMed ID: 8957627
    [No Abstract]   [Full Text] [Related]  

  • 13. Rhabdomyolysis with simvastatin and nefazodone.
    Thompson M; Samuels S
    Am J Psychiatry; 2002 Sep; 159(9):1607. PubMed ID: 12202291
    [No Abstract]   [Full Text] [Related]  

  • 14. Rhabdomyolysis due to bezafibrate in CAPD patients. A role for dihydropyridine drugs?
    Weissgarten J; Zaidenstein R; Fishman S; Dishi V; Michovitz-Koren M; Averbukh Z; Golik A
    Perit Dial Int; 1999; 19(2):180-2. PubMed ID: 10357195
    [No Abstract]   [Full Text] [Related]  

  • 15. Rhabdomyolysis resulting from interaction of simvastatin and clarithromycin demonstrated by Tc-99m MDP scintigraphy.
    Trieu J; Emmett L; Perera C; Thanakrishnan K; Van Der Wall H
    Clin Nucl Med; 2004 Dec; 29(12):803-4. PubMed ID: 15545884
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rhabdomyolysis secondary to simvastatin and phenofibrate].
    Forcadell-Peris MJ; de Diego-Cabanes C
    Semergen; 2014; 40(4):e91-4. PubMed ID: 24768027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute renal failure due to rhabdomyolysis in presence of concurrent ciprofibrate and ibuprofen treatment.
    Ramachandran S; Giles PD; Hartland A
    BMJ; 1997 May; 314(7094):1593. PubMed ID: 9186171
    [No Abstract]   [Full Text] [Related]  

  • 18. [Muscle toxicity of hypolipidemic agents revealed in hypothyroidism].
    Prudhomme F; Jacotot B
    Presse Med; 2003 Apr; 32(13 Pt 1):603-4. PubMed ID: 12718321
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of rhabdomyolysis and thromboembolic event secondary to fibrate monotherapy.
    Yildiz A; Gucuk E; Cay S
    Acta Cardiol; 2008 Aug; 63(4):515-7. PubMed ID: 18795591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin-fibrate combination therapy.
    Shek A; Ferrill MJ
    Ann Pharmacother; 2001; 35(7-8):908-17. PubMed ID: 11485144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.